Literature DB >> 21470339

Lack of association between the P2X7 receptor A1513C polymorphism and susceptibility to pulmonary tuberculosis: a meta-analysis.

Xiwen Wang1, Huaping Xiao, Haibing Lan, Chen Mao, Qing Chen.   

Abstract

BACKGROUND AND
OBJECTIVE: Genetic background may influence susceptibility pulmonary tuberculosis. The evidence for an association between the P2X7 receptor A1513C polymorphism and susceptibility to pulmonary tuberculosis remains inconclusive. In order to provide a more precise estimate of this association, a meta-analysis was performed.
METHODS: Databases, including PUBMED, OVID, ScienceDirect, SpringerLink, EBSCO and EMBASE were searched for publications that met the inclusion criteria. A fixed effect model was used to estimate pooled OR with 95% CI for the association between susceptibility to pulmonary tuberculosis and the P2X7 receptor A1513C polymorphism. The chi-squared-based Q-test was used to test the heterogeneity hypothesis. Begg's test and Egger's test were used to check publication bias.
RESULTS: Six published case-control studies that investigated the association between the P2X7 receptor A1513C polymorphism and susceptibility to pulmonary tuberculosis in 2525 subjects were included in this meta-analysis. The heterogeneity hypothesis test did not reveal any heterogeneity. Begg's test and Egger's test did not detect obvious publication bias among the included studies. This meta-analysis indicated that there was no significant association between the P2X7 receptor A1513C polymorphism and susceptibility to pulmonary tuberculosis (AC vs AA model: OR 1.12, 95% CI: 0.93-1.35; CC vs AA model: OR 1.45, 95% CI: 0.92-2.28; AC + CC vs AA model: OR 1.15, 95% CI: 0.96-1.13; CC vs AC + AA model: OR 1.42, 95% CI: 0.90-2.23).
CONCLUSIONS: This meta-analysis of six studies involving 2525 subjects suggested that the P2X7 receptor A1531C polymorphism is not associated with susceptibility to pulmonary tuberculosis.
© 2011 The Authors; Respirology © 2011 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21470339     DOI: 10.1111/j.1440-1843.2011.01976.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  6 in total

1.  Year in review 2011: respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging.

Authors:  José M Porcel; Chi Chiu Leung; Marcos I Restrepo; Pyng Lee
Journal:  Respirology       Date:  2012-04       Impact factor: 6.424

Review 2.  Innate immune gene polymorphisms in tuberculosis.

Authors:  Abul K Azad; Wolfgang Sadee; Larry S Schlesinger
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

3.  Gene polymorphisms in patients with pulmonary tuberculosis from Mozambique.

Authors:  Nédio Mabunda; Lucia Elena Alvarado-Arnez; Adolfo Vubil; Amina Mariamo; Antonio G Pacheco; Ilesh V Jani; Milton O Moraes
Journal:  Mol Biol Rep       Date:  2014-09-20       Impact factor: 2.316

Review 4.  P2RX7 at the Host-Pathogen Interface of Infectious Diseases.

Authors:  Alexandra Y Soare; Tracey L Freeman; Alice K Min; Hagerah S Malik; Elizabeth O Osota; Talia H Swartz
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-13       Impact factor: 11.056

5.  The effects of socioeconomic status, clinical factors, and genetic ancestry on pulmonary tuberculosis disease in northeastern Mexico.

Authors:  Bonnie N Young; Adrian Rendón; Adrian Rosas-Taraco; Jack Baker; Meghan Healy; Jessica M Gross; Jeffrey Long; Marcos Burgos; Keith L Hunley
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

6.  Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis.

Authors:  Eduardo P Amaral; Simone C M Ribeiro; Verônica R Lanes; Fabrício M Almeida; Marcelle R M de Andrade; Caio Cesar Barbosa Bomfim; Erika M Salles; Karina R Bortoluci; Robson Coutinho-Silva; Mario H Hirata; José M Alvarez; Elena B Lasunskaia; Maria Regina D'Império-Lima
Journal:  PLoS Pathog       Date:  2014-07-03       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.